ArticleStress biology2026
Yersinia pseudotuberculosis secretes an Fe (II)-binding effector to evade calprotectin-mediated nutritional immunity.
Article in Stress biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Iron is an essential cofactor for core metabolic processes and is critical to both host physiology and invading pathogens. While the competition between host and pathogen for ferric iron [Fe (III)] and heme has been well characterized, microbial strategies to overcome Fe (II) limitation-particularly under calprotectin (CP)-mediated Fe (II) chelation-remain poorly understood. In this study, we show that Yersinia pseudotuberculosis (Yptb) employs its type VI secretion system 1 (T6SS1) to acquire Fe (II) through secretion of the Fe (II)-binding effector SfeP. Deletion of sfeP significantly reduced bacterial loads in wild-type mice but not in CP-deficient mice, highlighting its essential role in virulence under CP-imposed Fe (II) restriction. Mechanistically, SfeP acts as a proteinaceous ferrousophore that specifically interacts with the outer-membrane porin OmpF to facilitate Fe (II) uptake, and the resulting SfeP-mediated iron homeostasis contributes critically to bacterial resistance against oxidative and acidic stress. Together, these findings uncover a T6SS-dependent Fe (II)-scavenging pathway in which SfeP cooperates with OmpF to counteract host nutritional immunity and promote Yptb virulence. This work not only underscores the versatility of T6SS in metal acquisition and stress adaptation, but also highlights the physiological significance of CP-mediated Fe (II) sequestration in host defense against bacterial infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.